W.A. De Vigier Award 2018

We are honored that Lukas Langenegger, CEO of hemotune AG is among the Top 16 of the W.A. De Vigier Award 2018.

hemotune raises CHF 5.1 million Series A funding

hemotune is awarded 0.5 million euros by EIT Health

hemotune AG receives grant from Innosuisse

General guide to sepsis symptoms

33'110 Deaths Due to Antibiotic-resistant Bacteria in Europe 2015: An Increasing Threat to Globa

H2020 SME Instrument Phase I funding

Hemotune receives grant from Innosuisse

Lukas Langenegger selected as a UBS Global Visionary: A magnetic force for healthcare

hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca

Welcome to the team of hemotune